This guide explains how to use extended-release injectable naltrexone as part of medication-assisted treatment (MAT) for opioid use disorder. It covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.
Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide This guide is for physicians using medication-assisted treatment for patients...
TIP 63: Medications for Opioid Use Disorder – Full Document (Including Executive Summary and Parts 1-5) This Treatment Improvement Protocol (TIP) reviews the use of the three Food and...
TIP 63: Medications for Opioid Use Disorder – Introduction to Medications for Opioid Use Disorder Treatment (Part 1 of 5) Part 1 of this Treatment Improvement Protocol (TIP) offers a general...
TIP 63: Medications for Opioid Use Disorder – Pharmacotherapy for Opioid Use Disorder (Part 3 of 5) Part 3 of this Treatment Improvement Protocol (TIP) describes general...
A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders This manual offers best practices to states, tribes, and local communities on...
Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update This advisory summarizes data on the use of sublingual and transmucosal...
SAMHSA's mission is to reduce the impact of substance abuse and mental illness on
America's communities.
5600 Fishers Ln • Rockville, MD 20857
1-877-SAMHSA-7 (1-877-726-4727)
